Biotheranostics stock
WebJan 6, 2024 · Published. Jan 6, 2024 1:28AM EST. M edical technology company Hologic Inc. has announced the acquisition of privately-held Biotheranostics Inc. in a deal worth … WebTheranos Inc. (/ ˈ θ ɛr. ə n. oʊ s /) was an American privately held corporation that was touted as a breakthrough health technology company. Founded in 2003 by then 19-year-old Elizabeth Holmes, Theranos raised more than US$700 million from venture capitalists and private investors, resulting in a $10 billion valuation at its peak in 2013 and 2014. The …
Biotheranostics stock
Did you know?
WebJan 8, 2024 · Hologic, Inc. HOLX recently announced its plans to acquire Biotheranostics, Inc., a privately held commercial-stage company providing molecular diagnostic tests for breast and metastatic cancers ... WebJan 6, 2024 · Biotheranostics is a privately-held company that sells molecular diagnostics tests for breast and metastatic cancers. Hologic said the company generated about $33 …
WebApr 1, 2024 · Stock quotes by finanzen.net Two crossed lines that form an 'X'. ... Biotheranostics, Inc., is a leading healthcare provider in the oncology field assisting physicians in the treatment of cancer ... WebNot Registered? Click here to start the process.. Loading
WebJan 8, 2024 · Hologic, Inc. (. HOLX Quick Quote. HOLX - Free Report) recently announced its plans to acquire Biotheranostics, Inc., a privately held commercial-stage company … WebJan 5, 2024 · Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial …
WebAdaptive Biotechnologies (NASDAQ: ADPT) focuses on immuno-sequencing diagnostics, specifically in oncology. It studies and researches sequencing to profile T-Cell and B-Cell Receptors. It incorporates immuno-sequencing into clinical care for diagnosis, prognosis, and monitoring of cancer patients. The company was founded in 2009 and is based in ...
WebJan 19, 2024 · Contact Data Lisa Whitmyer Biotheranostics, Inc. 216-513-7808 [email protected] fiba asia u18 women\u0027s championship 2022WebBiotheranostics, Inc. is a commercial-stage molecular diagnostics company that develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. The company is based in San Diego, CA and offers testing se rvices through its CLIA-certified, CAP-accredited laboratory that is directly ... fiba basketball flashscoreWebJan 5, 2024 · – Transaction Accelerates Hologic’s Entry into Oncology Growth Market, Provides New Lab Capabilities – – Hologic’s Commercial Resources, Expertise in … fiba asian championshipWebBiotheranostics is a molecular diagnostics company that develops and provides diagnostic, prognostic, and predictive tests that helps physicians in the treatment of cancer patients. It offers CancerTYPE ID, a gene expression test for metastatic patients with diagnostic ambiguity, and Breast Cancer Index, a tool for breast cancer patients. fiba asia schedulefiba banking associationWebBiotheranostics was acquired by Hologic in February 2024, and continues to offer its portfolio of proprietary genomic assays to support personalized disease management in oncology. Visit Hologic.com . Biotheranostics Nondiscrimination Notice. Download our PDF to view this notice in … fiba asia cup todayWebOct 29, 2024 · San Diego, CA, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biotheranostics announces the publication of results from the IDEAL study in Clinical Cancer Research which reports novel findings of the Breast ... fiba asian qualifiers 2022